HEALTHCARE
Global Oncology Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Oncology Market, By Cancer Types (Breast Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Colorectal Cancer, and Others), Cancer Diagnostics (Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In situ Hybridization), Cancer Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy) End-User (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics) Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global oncology market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Oncology is the branch of medicine concerned with the diagnosis, treatment, and research of cancer. This field includes solid tumors and blood malignancies, among other cancers that impact different body sections. Cancer patients are treated by oncologists, and medical specialists who specialize in this field, using a variety of therapies including immunotherapy, chemotherapy, radiation therapy, and surgery. The oncology market encompasses a wide range of operations, including the creation of diagnostic equipment, therapeutic medications, and cutting-edge treatment options. It also covers facilities for cancer treatment, supporting care, and clinical trials. To improve patient outcomes and quality of life, the industry also entails substantial research and innovation activities to find novel treatments and refine existing ones.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Government initiatives and funding for cancer research
- Growing awareness about cancer and its treatment options
RESTRAINTS
- High cost of cancer treatments
- Stringent regulatory approvals
OPPORTUNITIES
- Increasing investment in cancer research and development
- Growing demand for minimally invasive treatments
CHALLENGES
- Managing the high cost of treatment and care
- Addressing disparities in access to cancer care
SEGMENTATION
- Cancer Types
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Liver Cancer
- Ovarian Cancer
- Prostate Cancer
- Skin Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Blood Cancer
- Others
- Cancer Diagnostics
- Tumor Biomarker Test
- Imaging
- Biopsy
- Liquid Biopsy
- Immunohistochemistry
- In situ Hybridization
- Cancer Treatment
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- End-User
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Roche Holding AG
- Novartis International AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Merck & Co., Inc.
- AstraZeneca PLC
- Johnson & Johnson
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Oncology Market, by Cancer Types
- 3.2 Global Oncology Market, by Cancer Diagnostics
- 3.3 Global Oncology Market, by Cancer Treatment
- 3.4 Global Oncology Market, by End-User
- 3.5 Global Oncology Market, by Geography
- 3.6 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Increasing prevalence of cancer globally
- 5.1.2 Advancements in cancer diagnostics and treatments
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Government initiatives and funding for cancer research
- 5.2.2 Growing awareness about cancer and its treatment options
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High cost of cancer treatments
- 5.3.2 Stringent regulatory approvals
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Increasing investment in cancer research and development
- 5.4.2 Growing demand for minimally invasive treatments
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Managing the high cost of treatment and care
- 5.5.2 Addressing disparities in access to cancer care
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL ONCOLOGY MARKET, BY CANCER TYPES
- 6.1 Cancer Types Summary
- 6.2 Market Attractive Index
- 6.3 Global Oncology Market, by Cancer Types (2019-2032)
- SECTION 7 - GLOBAL ONCOLOGY MARKET, BY CANCER DIAGNOSTICS
- 7.1 Cancer Diagnostics Summary
- 7.2 Market Attractive Index
- 7.3 Global Oncology Market, by Cancer Diagnostics (2019-2032)
- SECTION 8 - GLOBAL ONCOLOGY MARKET, BY CANCER TREATMENT
- 8.1 Cancer Treatment Summary
- 8.2 Market Attractive Index
- 8.3 Global Oncology Market, by Cancer Treatment (2019-2032)
- SECTION 9 - GLOBAL ONCOLOGY MARKET, BY END-USER
- 9.1 End-User Summary
- 9.2 Market Attractive Index
- 9.3 Global Oncology Market, by End-User (2019-2032)
- SECTION 10 - GLOBAL ONCOLOGY MARKET, BY GEOGRAPHY
- 10.1 Regional Summary
- 10.2 Market Attractive Index
- 10.3 Global Oncology Market, by Geography (2019-2032)
- SECTION 11 - NORTH AMERICA ONCOLOGY MARKET
- 11.1 North America Summary
- 11.2 Market Attractive Index
- 11.3 North America Oncology Market, by Cancer Types (2019-2032)
- 11.4 North America Oncology Market, by Cancer Diagnostics (2019-2032)
- 11.5 North America Oncology Market, by Cancer Treatment (2019-2032)
- 11.6 North America Oncology Market, by End-User (2019-2032)
- 11.7 North America Oncology Market, by Country (2019-2032)
- 11.7.1 U.S.
- 11.7.2 Canada
- 11.7.3 Mexico
- 11.7.4 Rest of North America
- SECTION 12 - EUROPE ONCOLOGY MARKET
- 12.1 Europe Summary
- 12.2 Market Attractive Index
- 12.3 Europe Oncology Market, by Cancer Types (2019-2032)
- 12.4 Europe Oncology Market, by Cancer Diagnostics (2019-2032)
- 12.5 Europe Oncology Market, by Cancer Treatment (2019-2032)
- 12.6 Europe Oncology Market, by End-User (2019-2032)
- 12.7 Europe Oncology Market, by Country (2019-2032)
- 12.7.1 Germany
- 12.7.2 U.K.
- 12.7.3 France
- 12.7.4 Italy
- 12.7.5 Spain
- 12.7.6 Russia
- 12.7.7 The Netherlands
- 12.7.8 Belgium
- 12.7.9 Turkey
- 12.7.10 Rest of Europe
- SECTION 13 - ASIA-PACIFIC ONCOLOGY MARKET
- 13.1 Asia-Pacific Summary
- 13.2 Market Attractive Index
- 13.3 Asia-Pacific Oncology Market, by Cancer Types (2019-2032)
- 13.4 Asia-Pacific Oncology Market, by Cancer Diagnostics (2019-2032)
- 13.5 Asia-Pacific Oncology Market, by Cancer Treatment (2019-2032)
- 13.6 Asia-Pacific Oncology Market, by End-User (2019-2032)
- 13.7 Asia-Pacific Oncology Market, by Country (2019-2032)
- 13.7.1 China
- 13.7.2 India
- 13.7.3 Japan
- 13.7.4 South Korea
- 13.7.5 Singapore
- 13.7.6 Malaysia
- 13.7.7 Australia
- 13.7.8 Thailand
- 13.7.9 Philippines
- 13.7.10 Rest of Asia-Pacific
- SECTION 14 - SOUTH AMERICA ONCOLOGY MARKET
- 14.1 South America Summary
- 14.2 Market Attractive Index
- 14.3 South America Oncology Market, by Cancer Types (2019-2032)
- 14.4 South America Oncology Market, by Cancer Diagnostics (2019-2032)
- 14.5 South America Oncology Market, by Cancer Treatment (2019-2032)
- 14.6 South America Oncology Market, by End-User (2019-2032)
- 14.7 South America Oncology Market, by Country (2019-2032)
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Chile
- 14.7.4 Colombia
- 14.7.5 Rest of South America
- SECTION 15 - MIDDLE EAST AND AFRICA ONCOLOGY MARKET
- 15.1 Middle East and Africa Summary
- 15.2 Market Attractive Index
- 15.3 Middle East and Africa Oncology Market, by Cancer Types (2019-2032)
- 15.4 Middle East and Africa Oncology Market, by Cancer Diagnostics (2019-2032)
- 15.5 Middle East and Africa Oncology Market, by Cancer Treatment (2019-2032)
- 15.6 Middle East and Africa Oncology Market, by End-User (2019-2032)
- 15.7 Middle East and Africa Oncology Market, by Country (2019-2032)
- 15.7.1 Kingdom of Saudi Arabia
- 15.7.2 South Africa
- 15.7.3 U.A.E.
- 15.7.4 Egypt
- 15.7.5 Rest of Middle East and Africa
- SECTION 16 - COMPANY SHARE ANALYSIS
- 16.1 Global Oncology Market, Company Share Analysis
- 16.2 North America Oncology Market, Company Share Analysis
- 16.3 Europe Oncology Market, Company Share Analysis
- 16.4 Asia-Pacific Oncology Market, Company Share Analysis
- SECTION 17 - COMPANY PROFILES
- 17.1 Roche Holding AG
- 17.1.1 Company Snapshot
- 17.1.2 Financial Overview
- 17.1.3 Product Portfolio
- 17.1.4 Recent Developments
- 17.2 Novartis International AG
- 17.2.1 Company Snapshot
- 17.2.2 Financial Overview
- 17.2.3 Product Portfolio
- 17.2.4 Recent Developments
- 17.3 Bristol-Myers Squibb Company
- 17.3.1 Company Snapshot
- 17.3.2 Financial Overview
- 17.3.3 Product Portfolio
- 17.3.4 Recent Developments
- 17.4 Pfizer Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Financial Overview
- 17.4.3 Product Portfolio
- 17.4.4 Recent Developments
- 17.5 Merck & Co., Inc.
- 17.5.1 Company Snapshot
- 17.5.2 Financial Overview
- 17.5.3 Product Portfolio
- 17.5.4 Recent Developments
- 17.6 AstraZeneca PLC
- 17.6.1 Company Snapshot
- 17.6.2 Financial Overview
- 17.6.3 Product Portfolio
- 17.6.4 Recent Developments
- 17.7 Johnson & Johnson
- 17.7.1 Company Snapshot
- 17.7.2 Financial Overview
- 17.7.3 Product Portfolio
- 17.7.4 Recent Developments
- 17.8 Sanofi S.A.
- 17.8.1 Company Snapshot
- 17.8.2 Financial Overview
- 17.8.3 Product Portfolio
- 17.8.4 Recent Developments
- 17.9 Takeda Pharmaceutical Company Limited
- 17.9.1 Company Snapshot
- 17.9.2 Financial Overview
- 17.9.3 Product Portfolio
- 17.9.4 Recent Developments
- 17.10 Amgen Inc.
- 17.10.1 Company Snapshot
- 17.10.2 Financial Overview
- 17.10.3 Product Portfolio
- 17.10.4 Recent Developments
- SECTION 18 - RELATED REPORTS
- SECTION 19 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.